21-34363867-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000715813.1(KCNE2):​c.-294G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.515 in 152,102 control chromosomes in the GnomAD database, including 22,151 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 22151 hom., cov: 33)

Consequence

KCNE2
ENST00000715813.1 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.09
Variant links:
Genes affected
KCNE2 (HGNC:6242): (potassium voltage-gated channel subfamily E regulatory subunit 2) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, isk-related subfamily. This member is a small integral membrane subunit that assembles with the KCNH2 gene product, a pore-forming protein, to alter its function. This gene is expressed in heart and muscle and the gene mutations are associated with cardiac arrhythmia. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 21-34363867-G-A is Benign according to our data. Variant chr21-34363867-G-A is described in ClinVar as [Benign]. Clinvar id is 683556.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.738 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOC105372791NR_188571.1 linkn.852+6568C>T intron_variant Intron 2 of 2
KCNE2NM_172201.2 linkc.-297G>A upstream_gene_variant ENST00000290310.4 NP_751951.1 Q9Y6J6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNE2ENST00000715813.1 linkc.-294G>A 5_prime_UTR_variant Exon 5 of 6 ENSP00000520524.1
ENSG00000225555ENST00000440403.2 linkn.854+6568C>T intron_variant Intron 2 of 2 3
KCNE2ENST00000290310.4 linkc.-297G>A upstream_gene_variant 1 NM_172201.2 ENSP00000290310.2 Q9Y6J6

Frequencies

GnomAD3 genomes
AF:
0.515
AC:
78332
AN:
151984
Hom.:
22155
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.273
Gnomad AMI
AF:
0.613
Gnomad AMR
AF:
0.597
Gnomad ASJ
AF:
0.569
Gnomad EAS
AF:
0.758
Gnomad SAS
AF:
0.582
Gnomad FIN
AF:
0.631
Gnomad MID
AF:
0.649
Gnomad NFE
AF:
0.597
Gnomad OTH
AF:
0.544
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.515
AC:
78334
AN:
152102
Hom.:
22151
Cov.:
33
AF XY:
0.523
AC XY:
38872
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.273
AC:
11306
AN:
41482
American (AMR)
AF:
0.598
AC:
9142
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.569
AC:
1975
AN:
3468
East Asian (EAS)
AF:
0.758
AC:
3918
AN:
5170
South Asian (SAS)
AF:
0.583
AC:
2805
AN:
4814
European-Finnish (FIN)
AF:
0.631
AC:
6673
AN:
10568
Middle Eastern (MID)
AF:
0.636
AC:
187
AN:
294
European-Non Finnish (NFE)
AF:
0.597
AC:
40626
AN:
67998
Other (OTH)
AF:
0.542
AC:
1144
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1772
3544
5316
7088
8860
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.579
Hom.:
110832
Bravo
AF:
0.506
Asia WGS
AF:
0.634
AC:
2209
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
13
DANN
Benign
0.68
PhyloP100
1.1
PromoterAI
-0.023
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13048252; hg19: chr21-35736166; API